Inside story of Kodak's surge on $765m White House loan to pivot into drugs

Loading player...
Mostly forgotten photography icon Eastman Kodak jumped into the headlines this month after the Trump White House picked it out for special treatment in a plan to move production of chemicals that go into cornavirus drugs back to the US. The now tiny US company was incentivised through a $765m government loan - news of which sent its share price from $2 to over $60 before easing back to close the session at $33 and ease back further to its current $10, still five times the pre-loan announcement. Here's the inside story from our partners at the Wall Street Journal. Learn more about your ad choices. Visit megaphone.fm/adchoices
11 Aug 2020 10AM English South Africa Investing · Business News

Other recent episodes

Solly Moeng on Ramaphosa, his shadowy advisers and a fading legacy

In their weekly chat Chris Steyn and political commentator Solly Moeng dissect President Cyril Ramaphosa’s tough week on several fronts: The Madlanga Commission of Inquiry is seeking answers from his very influential former adviser, Dr Bejani Chauke, particularly in relation to WhatsApp chats with a notorious late taxi boss; his…
29 Oct 10AM 21 min